GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Relevium Technologies Inc (TSXV:RLV.H) » Definitions » Research & Development

Relevium Technologies (TSXV:RLV.H) Research & Development : C$0.00 Mil (TTM As of Mar. 2022)


View and export this data going back to 2012. Start your Free Trial

What is Relevium Technologies Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Relevium Technologies's Research & Development for the three months ended in Mar. 2022 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2022 was C$0.00 Mil.

Relevium Technologies Research & Development Historical Data

The historical data trend for Relevium Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relevium Technologies Research & Development Chart

Relevium Technologies Annual Data
Trend Dec12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Relevium Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Mar22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Relevium Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relevium Technologies  (TSXV:RLV.H) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Relevium Technologies Research & Development Related Terms

Thank you for viewing the detailed overview of Relevium Technologies's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Relevium Technologies (TSXV:RLV.H) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Relevium Technologies Inc (TSXV:RLV.H) » Definitions » Research & Development
Comparable Companies
TSXV:LOTA WAR:TGS NEOE:TREE XCNQ:IWIN BOM:513430 HEWA HKSE:02211 TSXV:KO SSY BOM:501477
Traded in Other Exchanges
N/A
Address
1000 Sherbrooke Street West, Suite 2700, Montreal, QC, CAN, H3A 3G4
Website
https://www.releviumtechnologies.com
Relevium Technologies Inc is a Canada based company operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition, and operations of brands and businesses in the health and wellness markets including medical cannabis. Its operating segment includes Consumer Packaged Goods (CPG); Pediatric Biopharma and Corporate. The company generates maximum revenue from Consumer Packaged Goods segment.

Relevium Technologies (TSXV:RLV.H) Headlines

No Headlines